Company intelligence / Profile preview

Avanzcare

Ownership: Private
Development stage: Commercial

Overview

Avanzcare is a Qatari healthcare company focused on pharmaceutical distribution, manufacturing, healthcare centers, and retailing. It acts as the exclusive MENA region distributor for select vaccines such as Flublok and Panblok from Protein Sciences Corporation. The company has also secured partnerships with global medical device firms like Mindray for distribution in Qatar. There is no public evidence that Avanzcare develops its own proprietary drugs or biologics[1][2][4][5].

Therapeutic areas: Infectious Diseases
Modalities: Vaccine
Industry: Non-Academic Healthcare

Drug pipeline

2 assets

Flublok

Commercial

Indications: Influenza

1 more asset in the full pipeline.

Request access →

Partnerships

Protein Sciences CorporationMindray

Beyond the preview

Go deeper on Avanzcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avanzcare.

Explore the full profile